絞り込み

16636

広告

Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study.

著者 Hobart M , Skuban A , Zhang P , Josiassen MK , Hefting N , Augustine C , Brewer C , Sanchez R , McQuade RD
Curr Med Res Opin.2018 Jan 17 ; ():1-29.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (20view , 0users)

Full Text Sources

To assess the efficacy, safety and tolerability of brexpiprazole as adjunctive treatment in adults with major depressive disorder (MDD) and an inadequate response to prior antidepressant treatment (ADT).
PMID: 29343128 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード